What is Repligen's AOCI?

Repligen (RGEN) reported AOCI of -$14.31M in Q1 2026.

How has Repligen's AOCI changed year-over-year?

Repligen's AOCI increased by 70.1% year-over-year, from -$47.84M to -$14.31M.

What is the long-term trend for Repligen's AOCI?

Over 5 years (2020 to 2025), Repligen's AOCI has grown at a 4.0% compound annual growth rate (CAGR), from $2.09M to -$2.53M.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Repligen RGEN AOCI

AOCI at other companies

TEC

Bio-TechneTECH

-$66.86M+18.5%

RevvityRVTY

-$253.56M+19.9%

Thermo Fisher ScientificTMO

-$2.5B-6.6%

DanaherDHR

-$593M+63.2%

Agilent TechnologiesA

-$202M+27.9%

Bio-Rad LaboratoriesBIO

-$235.4M+42.6%

Other financials

Income statement

See full

Revenue$194.3M+14.8%

Gross profit$108.3M+18.5%

Operating income$15.9M+142%

Net income$8.3M+42.9%

EPS (diluted)$0.15+50.0%

Balance sheet

See full

Cash & equivalents$582.7M-16.4%

Total debt$687.6M+346%

Total equity$2.1B+6.0%

Total assets$2.9B+2.8%

Cash flow

See full

Operating cash flow$28.3M+88.6%

CapEx$4.7M+32.2%

Free cash flow$23.6M+106%

Valuation

See full

Market cap$7.45B-7.1%

Enterprise value$7.55B+2.1%

P/E144.9×—

P/S10.1×-0.1×

Profitability

See full

Gross margin49.5%+2.7pp

Operating margin1.5%-14.0pp

Net margin17.1%-3.7pp

FCF margin21.2%+6.1pp

Returns & leverage

See full

Return on equity2.5%+1.9pp

Debt / equity0.3×+0.2×

Current ratio9.2×+2.4×

Where this comes from

Reported directly by Repligen in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Repligen’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Repligen's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Repligen's AOCI?: Repligen (RGEN) reported AOCI of -$14.31M in Q1 2026.
How has Repligen's AOCI changed year-over-year?: Repligen's AOCI increased by 70.1% year-over-year, from -$47.84M to -$14.31M.
What is the long-term trend for Repligen's AOCI?: Over 5 years (2020 to 2025), Repligen's AOCI has grown at a 4.0% compound annual growth rate (CAGR), from $2.09M to -$2.53M.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.